Viridian Therapeutics (1S1.F) Q4 2024 Earnings

Nov 12Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.25
-1.08
-0.91
-0.73

Details

Expected EPS
-0.9958766375
Actual EPS
-1.0832424999999999
Surprise EPS
-0.09
Surprise Percent
-8.77%

Description

⁨Viridian Therapeutics⁩ (⁦1S1.F⁩) has reported earnings of ⁦-1.0832424999999999⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts